Rifampin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Rifampin Injection (injection) from Mylan Institutional, A Viatris Company with status Current. The shortage was first posted on Feb 17, 2021. Reported reason: Demand increase for the drug
Shortage details
- Status
- Current
- Company
- Mylan Institutional, A Viatris Company
- Package NDC
- 67457-445-60
- Dosage Form
- Injection
- Presentation
- Rifampin, Injection, 600 mg (NDC 67457-445-60)
- Initial Posting
- Feb 17, 2021
Reason
Demand increase for the drug